In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
November 7th, 2005 | 21 | Yes |
None
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 2.31 | 3.26 | -48.69 | 4 | 4 | 1 | 66 | 286.351 | 3 | ↓ |
Mid Mid (pH 6-8) | 2.31 | 1.99 | -8.11 | 3 | 4 | 0 | 62 | 285.343 | 3 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
UniProt Database Links | 4OMT_COPJA; 6OMT_COPJA; CNMT_THLFG | ChEBI |
PUBCHEM_PATENT_ID | EP0154035A2; EP0355575A2; EP0355575B1; EP0872903A1; EP0931544A2; US4657861; US4757124; US4758639; US5196164; US5298220; US6096144; US6123943 | IBM Patent Data |
Patent Database Links | EP0931544 | ChEBI |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
DRD1-1-E | Dopamine D1 Receptor (cluster #1 Of 4), Eukaryotic | Eukaryotes | 240 | 0.44 | Binding ≤ 10μM |
Z50607-1-O | Human Immunodeficiency Virus 1 (cluster #1 Of 10), Other | Other | 2800 | 0.37 | Functional ≤ 10μM |
DRD2-2-E | Dopamine D2 Receptor (cluster #2 Of 24), Eukaryotic | Eukaryotes | 130 | 0.46 | Binding ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
DRD1_RAT | P18901 | Dopamine D1 Receptor, Rat | 240 | 0.44 | Binding ≤ 1μM |
DRD2_RAT | P61169 | Dopamine D2 Receptor, Rat | 130 | 0.46 | Binding ≤ 1μM |
DRD1_RAT | P18901 | Dopamine D1 Receptor, Rat | 240 | 0.44 | Binding ≤ 10μM |
DRD2_RAT | P61169 | Dopamine D2 Receptor, Rat | 130 | 0.46 | Binding ≤ 10μM |
Z50607 | Z50607 | Human Immunodeficiency Virus 1 | 2800 | 0.37 | Functional ≤ 10μM |
Description | Species |
---|---|
Dopamine receptors | |
G alpha (i) signalling events |